Abstract:Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (9): 4098-4102. DOI: 10.26355/eurrev_202305_32317-PMID: 37203835-published online on May 15, 2023. After publication, the authors applied a correction in the Funding section. The section has been amended as follows: This study was supported by the research program of Jilin Provincial Science and Technology Department (No. 20190201011J). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/32317.

Corrigendum to “effects of a Symptom Management Intervention Based on Group Sessions Combined with a Mobile Health Application for Persons Living with HIV in China: A Randomized Controlled Trial” [int J Nurs Sci 8 (2021) 370–379]

Corrigendum to “sex Differences in HIV Treatment Outcomes and Adherence by Exposure Groups among Adults in Guangdong, China: A Retrospective Observational Cohort Study” [eclinicalmedicine 22 (2020) 100351]

Corrigendum: A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China

Corrigendum: Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020–2021: Impact on medication adherence

Correction to: Empowerment-Led Guided Self-Help Intervention for Symptom Burden in Breast Cancer Women Treated With Ovarian Function Suppression: A Randomized Trial Protocol

Correction: Corrigendum: Quality of Life and Cost-Effectiveness of Radiofrequency Ablation versus Open Surgery for Benign Thyroid Nodules: a retrospective cohort study

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Corrigendum to ‘oral Azvudine for Hospitalised Patients with COVID-19 and Pre-Existing Conditions: a Retrospective Cohort Study.’ [eclinicalmedicine 59 (2023) 101981]

Corrigendum to “Treatment-Related Adverse Events Associated with HER2-Targeted Antibody-Drug Conjugates in Clinical Trials: a Systematic Review and Meta-Analysis” [eclinicalmedicine 55 (2022) 101795]

Corrigendum to “evaluation of a Whole Process Management Model Based on an Information System for Cancer Patients with Pain: A Prospective Nonrandomized Controlled Study” [Asia-Pacific J Oncol Nurs 9 (2022) 88–96]

Corrigendum to "trend of HIV-1 Drug Resistance in China: A Systematic Review and Meta-Analysis of Data Accumulated over 17 Years (2001-2017)" [eclinicalmedicine 18 (2020) 100238].

Corrigendum to “The Efficacy and Safety of Chinese Herbal Decoction in Type 2 Diabetes: A 5-Year Retrospective Study”

Corrigendum to "Digital exclusion and functional dependence in older people: findings from five longitudinal cohort studies" eClinical Medicine 54 (2022) 101708

Correction to: Pilot randomized sham-controlled trial of self-acupressure to manage the symptom cluster of insomnia, depression, and anxiety in cancer patients undergoing chemotherapy

Corrigendum to “Knowledge of Opioid-induced Respiratory Depression Among Chinese Healthcare Professionals: A Cross-Sectional Study” [Asia-Pacific J Oncol Nursing 9 (2022) 55–60]

Corrigendum: A Randomized Controlled Trial of a Coping-Focused Family Resilience Intervention Program for Breast Cancer Patients: Study Protocol

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

Corrigendum: Development and initial validation of a clinical measure to assess symptoms of post-stroke depression in stroke patients at the rehabilitation stage

Corrigendum to “the Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials” by Yuqi Liu,Juan Li, Jinfang Ma, Nanwei Tong

Corrigendum: Investigating the relationship between hepatitis B virus infection and postpartum depression in Chinese women: a retrospective cohort study

Corrigendum: A matter of life or death: Productively infected and bystander CD4 T Cells in early HIV infection